Document ID: chunk:federal_register_of_legislation:F2025L00215:schedule:1:p50
Version: federal_register_of_legislation:F2025L00215
Segment Type: schedule
Provision Reference: sch 1 (pt 50/51)
Character Range: 187022–191373

Exarane
                                                                                                                                    Exarane Safety-Lock
Enoxaparin  GRP-28012  Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe  Injection  Clexane Forte Safety-Lock
                                                                                                                                    Exarane Forte
                                                                                                                                    Exarane Forte Safety-Lock
Enoxaparin  GRP-28013  Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe    Injection  Clexane Forte Safety-Lock
                                                                                                                                    Exarane Forte
                                                                                                                                    Exarane Forte Safety-Lock

[130] Schedule 5, entry for Entecavir [GRP-21170]
omit from the column headed "Brand": Entecavir Mylan
[131] Schedule 5, entry for Erlotinib [GRP-24881]
insert in the column headed "Brand" after entry for the Brand "Erlotinib APOTEX": ERLOTINIB ARX
[132] Schedule 5, omit entry for Estradiol [GRP-28651]
[133] Schedule 5, after entry for Estradiol [GRP-29376]
insert:
Estradiol                      GRP-29483  Transdermal patches 1.56 mg, 24 (Sandoz) (S19A)                                                                        Transdermal  Estramon (Germany, Sandoz)
Estradiol                      GRP-29483  Transdermal patches 1.56 mg, 24 (S19A)                                                                                 Transdermal  Estramon 100 (Germany)
Estradiol with norethisterone  GRP-29485  Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8         Transdermal  Estalis continuous 50/140
Estradiol with norethisterone  GRP-29485  Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 (S19A)  Transdermal  ESTALIS 140/50 (Canada)
Estradiol with norethisterone  GRP-29487  Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8         Transdermal  Estalis continuous 50/250
Estradiol with norethisterone  GRP-29487  Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 (S19A)  Transdermal  ESTALIS 250/50 (Canada)

[134] Schedule 5, entry for Ethosuximide in the form Capsule 250 mg [GRP-23067]
omit from the column headed "Brand": Zarontin substitute: ZARONTIN
[135] Schedule 5, entry for Ezetimibe and rosuvastatin [GRP-22369]
insert in the column headed "Brand" after entry for the Brand "Ezalo Composite Pack 10mg+40mg": Ezetimibe - Rosuvastatin Sandoz 10 mg/40 mg
[136] Schedule 5, entry for Ezetimibe and rosuvastatin [GRP-22388]
insert in the column headed "Brand" after entry for the Brand "Ezalo Composite Pack 10mg+10mg": Ezetimibe - Rosuvastatin Sandoz 10 mg/10 mg
[137] Schedule 5, entry for Ezetimibe and rosuvastatin [GRP-22395]
insert in the column headed "Brand" after entry for the Brand "Ezalo Composite Pack 10mg+20mg": Ezetimibe - Rosuvastatin Sandoz 10 mg/20 mg
[138] Schedule 5, entry for Ezetimibe and rosuvastatin [GRP-22399]
insert in the column headed "Brand" after entry for the Brand "Ezalo Composite Pack 10mg+5mg": Ezetimibe - Rosuvastatin Sandoz 10 mg/5 mg
[139] Schedule 5, entries for Irbesartan
omit from the column headed "Brand" (all instances): Irbesartan GH
[140] Schedule 5, after entry for Leflunomide [GRP-19866]
insert:
Lenalidomide  GRP-29484  Capsule 20 mg  Oral  Lenalide
                                              Lenalidomide Sandoz

[141] Schedule 5, entry for Metformin [GRP-19608]
insert in the column headed "Brand" after entry for the Brand "METEX XR": Metformin Sandoz XR
[142] Schedule 5, entry for Metformin [GRP-24200]
substitute:
Metformin  GRP-24200  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  APO-Metformin XR 500
                                                                                                 Diabex XR 500